Advanced Stage Protein Therapeutics Shows Promising Market

Backed by expected launch of late stage clinical trials products, the global protein therapeutics market may grow at a CAGR of around 8% during 2012-2015, says RNCOS.

Noida, India (prHWY.com) April 30, 2012 - According to our new report, entitled "Global Protein Therapeutics Market Forecast to 2015", protein-based therapies have become one of the most effective clinical methods to treat wide spectrum of diseases ranging from cancer to metabolic disorders. Since the launch of the first recombinant protein therapeutic product (human insulin), the market has been advancing at the rapid pace. In 2011, the global protein therapeutics market is estimated to have reached around US$ 105 Billion and is likely to expand at a CAGR of around 8% during 2012-2015. The market is propelled by factors such as attractive portfolio of advanced clinical trials products and increasing incidences of life threatening diseases.

The report has found that there are many key protein therapeutic products under the phase-3 clinical trial development stage that may offer huge growth potential in future upon commercialization. The most promising pipeline is for the monoclonal antibody (mAb) products owing to the efficacy and specificity that they offer. These mAbs are being researched for the treatment of cancer, multiple sclerosis, and rheumatoid arthritis. Insulin products from companies, such as Eli Lily and Sanofi are also of great benefit and have already entered the late phase of development stage.

The report covers all the key aspects of the market and provides an in-depth insight into the key industry segments. It prudently analyzes all the industry segments in an effective manner by focusing on major players and products, recent developments, application support in terms of indications, geographical performance, and last but not the least, current and future market size. The report also investigates the current market trends and elucidates their impact on the current and future market performance.

The report is an outcome an extensive research and prudent analysis of global protein therapeutics market that seeks to provide reliable statistics and effective presentation. It also gives an optimum outlook on the overall sector and key segments till 2015. While doing the forecast, a key emphasis has been towards the applied methods and techniques, past trends, and key drivers. A brief description and key developments with respect to industry players have also been provided. Overall, the report will prove to be a complete source of knowledge and analysis for clients and potential investors.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM389.htm

Some of our Related Reports are:

- Cancer Monoclonal Antibodies Market to 2015
- Global Biosimilars Market Forecast to 2015
- US Biotech Market Analysis
- Global miRNA Market Outlook
- Global HIV Therapeutics Market Analysis

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: global interferon market

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code